Stigmasterol accumulation causes cardiac injury and promotes mortality

Cardiovascular disease is expected to remain the leading cause of death worldwide despite the introduction of proprotein convertase subtilisin/kexin type 9 inhibitors that effectively control cholesterol. Identifying residual risk factors for cardiovascular disease remains an important step for prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Caroline, Shkumatov, Artem A., Alexander, Shawn T., Ason, Brandon L., Zhou, Mingyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335236/
https://www.ncbi.nlm.nih.gov/pubmed/30675518
http://dx.doi.org/10.1038/s42003-018-0245-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335236/
https://www.ncbi.nlm.nih.gov/pubmed/30675518
http://dx.doi.org/10.1038/s42003-018-0245-x

Ejemplares similares